Viatris Inc (VTRS)
12.49
-0.03
(-0.24%)
USD |
NASDAQ |
Dec 23, 16:00
12.45
-0.04
(-0.32%)
Pre-Market: 08:14
Viatris Cash from Investing (Quarterly): 1.748B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 53.47M |
| Moderna Inc | 721.00M |
| Baxter International Inc | -164.00M |
| Gilead Sciences Inc | -710.00M |
| Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 826.50M |
| Cash from Financing (Quarterly) | -1.637B |
| Free Cash Flow | 1.893B |
| Free Cash Flow Per Share (Quarterly) | 0.6174 |
| Free Cash Flow to Equity (Quarterly) | 2.090B |
| Free Cash Flow to Firm (Quarterly) | 893.62M |
| Free Cash Flow Yield | 12.60% |